Schizophrenia
|
0.400 |
Biomarker
|
disease |
BEFREE |
Mutant mice heterozygous for either NRG1 or its receptor, ErbB4, show a behavioral phenotype that overlaps with mouse models for schizophrenia.
|
12145742 |
2002 |
Schizophrenia
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Our data require independent replication, but tentatively suggest that NRG1 may mediate its effects on schizophrenia susceptibility through functional interaction with erbB4, and that genetic interaction between variants at the two loci increases susceptibility to schizophrenia.
|
16249994 |
2006 |
Schizophrenia
|
0.400 |
AlteredExpression
|
disease |
LHGDN |
Schizophrenia subjects showed substantial increases in erbB4-PSD-95 interactions.
|
16767099 |
2006 |
Schizophrenia
|
0.400 |
Biomarker
|
disease |
BEFREE |
We propose that NRG1 and its receptor ErbB4 are components of a biological pathway, involved in the pathophysiology of schizophrenia.
|
16402353 |
2006 |
Schizophrenia
|
0.400 |
Biomarker
|
disease |
BEFREE |
Attenuated NRG1 signaling through ErbB4 may contribute to the pathophysiology of schizophrenia through dysfunction of NMDAR modulation.
|
17460065 |
2007 |
Schizophrenia
|
0.400 |
AlteredExpression
|
disease |
LHGDN |
These findings suggest that dysregulation of splice-variant specific expression of ErbB4 in the brain underlies the genetic association of the gene with schizophrenia and that the NRG1/ErbB4 signaling pathway may be an important genetic network involved in the pathogenesis of the disease.
|
17164265 |
2007 |
Schizophrenia
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
These findings suggest that dysregulation of splice-variant specific expression of ErbB4 in the brain underlies the genetic association of the gene with schizophrenia and that the NRG1/ErbB4 signaling pathway may be an important genetic network involved in the pathogenesis of the disease.
|
17164265 |
2007 |
Schizophrenia
|
0.400 |
Biomarker
|
disease |
BEFREE |
The glutamatergic hypothesis of schizophrenia lead recently to a first successful mGlu2/3 receptor agonistic drug and is underpinned by significant findings in genes regulating the glutamatergic system (SLC1A6, SLC1A2 GRIN1, GRIN2A, GRIA1, NRG1, ErbB4, DTNBP1, DAAO, G72/30, GRM3).
|
17982252 |
2007 |
Schizophrenia
|
0.400 |
Biomarker
|
disease |
BEFREE |
We hypothesize that ErbB4 proteolytic processing may also be altered in schizophrenia, yielding altered ratios of functionally distinct forms of ErbB4.
|
18243664 |
2008 |
Schizophrenia
|
0.400 |
Biomarker
|
disease |
BEFREE |
An improved understanding of the mechanisms by which altered function of NRG1 and ErbB4 contributes to schizophrenia might eventually lead to the development of more effective therapeutics.
|
18478032 |
2008 |
Schizophrenia
|
0.400 |
Biomarker
|
disease |
BEFREE |
In this study, we used the yeast two-hybrid system to identify proteins that interact with ERBB4, to identify genes and pathways that might contribute to schizophrenia susceptibility.
|
17579610 |
2008 |
Schizophrenia
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Thus, our results suggest the possibility that interaction between variants in NRG1 and ERBB4 might contribute to susceptibility for schizophrenia in a Japanese population.
|
18704261 |
2008 |
Schizophrenia
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
As FA is considered to index structural integrity of WM, to which neuronal fiber myelination is contributing, our results suggest that variations of the ErbB4 genotype may confer risk for schizophrenia illness via its impact on left frontotemporal connectivity in human brain.
|
18668031 |
2009 |
Schizophrenia
|
0.400 |
Biomarker
|
disease |
BEFREE |
Moreover, recent molecular genetics studies implicate ErbB4 in the pathophysiology of schizophrenia.
|
18854870 |
2009 |
Schizophrenia
|
0.400 |
Biomarker
|
disease |
BEFREE |
Like DISC1 and NRG1, OLIG2 and ERBB4 are promising candidate susceptibility genes for schizophrenia.
|
18996920 |
2009 |
Schizophrenia
|
0.400 |
Biomarker
|
disease |
BEFREE |
These observations suggest that ErbB4 is expressed in the dopaminergic neurons of primate substantia nigra and ErbB4 abnormality might contribute to the dopaminergic pathology associated with schizophrenia or other brain diseases.
|
19336245 |
2009 |
Schizophrenia
|
0.400 |
Biomarker
|
disease |
BEFREE |
A review of the clinical data indicates that in schizophrenia the Wnt pathway is most likely hypoactive, whereas the Nrg1-ErbB4, the TGF-beta- and the BDNF-p75-pathways are hyperactive.
|
19046988 |
2009 |
Schizophrenia
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Our findings demonstrate convergence between ERalpha and ErbB4-ICD in the transcriptional control of ERalpha-target gene expression and suggest that this may represent a convergent pathway that may be disrupted in schizophrenia.
|
19439407 |
2009 |
Schizophrenia
|
0.400 |
Biomarker
|
disease |
BEFREE |
Presenilins are a group of proteins playing an important role in the Notch, ErbB4 and Wnt signaling pathways possibly associated with schizophrenia.
|
19232479 |
2009 |
Schizophrenia
|
0.400 |
Biomarker
|
disease |
BEFREE |
The hypothesis has been recently emphasized in this Journal that the loss of synaptic spines with NMDA receptors, which can be precipitated by stress, can explain the emergence of positive symptoms such as hallucinations and that this synapse regression involves molecules such as neuregulin and its receptor ErbB4 that have been implicated in schizophrenia.
|
19629792 |
2009 |
Schizophrenia
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
The findings support the involvement of the ERBB4 gene in schizophrenia in Han Chinese.
|
20600594 |
2010 |
Schizophrenia
|
0.400 |
Biomarker
|
disease |
BEFREE |
Next, the review focuses on the possible significance of genetic studies associating NRG1 and ErbB4 with schizophrenia, in light of the functional role of this signaling pathway in regulating glutamatergic, GABAergic and dopaminergic neurotransmission, as well as modulating synaptic plasticity and gamma oscillations.
|
20688137 |
2010 |
Schizophrenia
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Several genes in the NRG-ErbB signaling pathway including NRG1 and ErbB4 have been implicated in genetic predisposition to schizophrenia.
|
20713722 |
2010 |
Schizophrenia
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
In addition, we consider molecular substrates upon which the NRG1-erbB4 and other, candidate pathways converge contributing to susceptibility for the illness (schizophrenia interactome).
|
20433909 |
2010 |
Schizophrenia
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
In this study, we investigate the role of rare coding variants in ERBB4 in BP cases with mood-incongruent psychotic features, a form of BP with arguably the greatest phenotypic overlap with schizophrenia.
|
21637803 |
2011 |